[en] Aims: To investigate whether BM-573 (N-tert-butyl-N'-[2-(4'-methylphenylam\ino)-5-nitro-benzenesulfonyl]urea), an original combined thromboxane A(2) synthase inhibitor and receptor antagonist, prevents reperfusion injury in acutely ischemic pigs. Methods: Twelve animals were randomly divided in two groups: a control group (n = 6) intravenously infused with vehicle, and a BM-573-treated group (n = 6) infused with BM-573 (10 mg kg(-1) h(-1)). In both groups, the left anterior descending (LAD) coronary artery was Occluded for 60 min and reperfused for 240 min. Either vehicle or BM-573 was infused 30 min before LAD occlusion and throughout the experiment. Platelet aggregation induced by arachidonic acid ex vivo measured was prevented by BM-573. Results: In both groups, LAD occlusion decreased cardiac output, ejection fraction, slope of stroke work-end-diastolic volume relationship, and induced end-systolic pressure-volume relationship (ESPVR) rightward shift, while left ventricular afterload increased. Ventriculo-arterial coupling and mechanical efficiency decreased. In both groups, reperfusion further decreased cardiac output and ejection fraction, while ESPVR displayed a further rightward shift. Ventriculo-arterial coupling and mechanical efficiency remained impaired. Area at risk, evidenced with Evans blue, was 33.2 +/- 3.4% of the LV mass (LVM) in both groups, and mean infarct size, revealed by triphenyltetrazolium chloride (TTC), was 27.3 +/- 2.6% of the LVM in the BM-573-treated group (NS). Histological examination and immunohistochemical identification of desmin revealed necrosis in the anteroseptal region similar in both groups, while myocardial ATP dosages and electron microscopy also showed that BM-573 had no cardioprotective effect. Conclusions: These data suggest that BM-573 failed to prevent reperfusion injury in acutely ischemic pigs. (C) 2005 Elsevier Inc. All rights reserved.
Disciplines :
Biochemistry, biophysics & molecular biology Cardiovascular & respiratory systems
Author, co-author :
Kolh, Philippe ; Université de Liège - ULiège > Services généraux (Fac. de psycho. et des sc. de l'éducat.) > Relations académiques et scientifiques (Psycho et sc.éduc.) - Relations académiques et scientifiques (Sciences)
Rolin, S.
Tchana-Sato, Vincent ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie cardio-vasculaire
Petein, M.
Ghuysen, Alexandre ; Université de Liège - ULiège > Département des sciences de la santé publique > Réanimation - Urgence extrahospitalière
Lambermont, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Frais communs médecine
GISSI Investigators. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1986;1:397.
C.L. Grines, K.F. Browne, and J. Marco A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group N Engl J Med 328 1993 673
F. Zijlstra, M.J. de Boer, J.C. Hoorntje, S. Reiffers, J.H. Reiber, and H. Suryapranata A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction N Engl J Med 328 1993 680
GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. N Engl J Med 1993;329:673.
D.J. Hearse, S.M. Humphrey, W.G. Nayler, A. Slade, and D. Border Ultrastructural damage associated with reoxygenation of the anoxic myocardium J Mol Cell Cardiol. 7 1975 315
L.H. Opie Reperfusion injury and its pharmacologic modification Circulation 80 1989 1049
K.A. Reimer, M. Tanaka, C.E. Murry, V.J. Richard, and R.B. Jennings Evaluation of free radical injury in myocardium Toxicol Pathol 18 1990 470
Y. Haga, N. Hatori, M. Nordlander, R. Nordlander, P.O. Sjoquist, and L. Ryden Coronary venous retroinfusion of felodipine reducing infarct size without affecting regional myocardial blood flow Eur Heart J 14 1993 1386
N. Hatori, Y. Haga, P.O. Sjoquist, M. Nordlander, and L. Ryden Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion J Cardiovasc Pharmacol 22 1993 160
Q.D. Wang, X.S. Li, J.M. Lundberg, and J. Pernow Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig Cardiovasc Res 29 1995 805
D.J. Fitzgerald, L. Roy, F. Catella, and G.A. FitzGerald Platelet activation in unstable coronary disease N Engl J Med 315 1986 983
M. Tada, T. Kuzuya, S. Hoshida, and M. Nishida Arachidonate metabolism in myocardial ischemia and reperfusion J Mol Cell Cardiol 20 Suppl. 2 1988 135
M. Tanabe, Z.I. Terashita, and S. Fujiwara Coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion in anaesthetised dogs Cardiovasc Res 16 1982 99
T. Kuzuya, S. Hoshida, M. Nishida, Y. Kim, T. Kamada, and M. Tada Increased production of arachidonate metabolites in an occlusion-reperfusion model of canine myocardial infarction Cardiovasc Res 21 1987 551
K. Higo, J. Sano, A. Karasawa, and K. Kubo The novel thromboxane A2 receptor antagonist KW-3635 reduces infarct size in a canine model of coronary occlusion and reperfusion Arch Int Pharmacodyn Ther 323 1993 32
A.M. Bhat, H. Sacks, J.A. Osborne, and A.M. Lefer Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats Am Heart J 117 1989 799
P. Golino, G. Ambrosio, and B. Villari Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion J Am Coll Cardiol 21 1993 493
Z.D. Ge, J.A. Auchampach, G.M. Piper, and G.J. Gross Comparison of cardioprotective efficacy of two thromboxane A2 receptor antagonists J Cardiovasc Pharmacol 41 2003 481
S. Rolin, J.M. Dogne, C. Michaux, J. Delarge, and B. Masereel Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles Prostaglandins Leukot Essent Fatty Acids 65 2001 67
S. Rolin, M. Petein, and V. Tchana-Sato BM-573, a dual thromboxane synthase inhibitor and thromboxane receptor antagonist, prevents pig myocardial infarction induced by coronary thrombosis J Pharmacol Exp Ther 306 2003 59
Dogne JM, Hanson J, de Leval X, et al. Pharmacological characterization of N-tert-butyl-N′-[2-(4′-methylphenylamino)-5-nitrobenzenesulfonyl] urea (BM-573), a novel thromboxane A2 receptor antagonist and thromboxane synthase inhibitor in a rat model of arterial thrombosis and its effects on bleeding time. J Pharmacol Exp Ther 2004;309:498.
J. Baan, E.T. van der Velde, and H.G. De Bruin Continuous measurement of left ventricular volume in animals and humans by conductance catheter Circulation 70 1984 812
H. Suga, A. Kitabatake, and K. Sagawa End-systolic pressure determines stroke volume from fixed end-diastolic volume in the isolated canine left ventricle under a constant contractile state Circ Res 44 1979 238
H. Suga External mechanical work from relaxing ventricle Am J Physiol 236 1979 H494 (Heart Circ Physiol 5)
S. Denslow Relationship between PVA and myocardial oxygen consumption can be derived from thermodynamics Am J Physiol 270 1996 H730 (Heart Circ Physiol 39)
N. Westerhof, G. Elzinga, and P. Sipkema An artificial arterial system for pumping hearts J Appl Physiol 31 1971 776
B. Lambermont, P. Kolh, O. Detry, P. Gerard, R. Marcelle, and V. D'Orio Analysis of endotoxin effects on the intact pulmonary circulation Cardiovasc Res 41 1999 275
K. Sagawa L. Maughan H. Suga K. Sunagawa Cardiac contraction and the pressure-volume relationship 1988 Oxford University Press New York
K. Higo, A. Karasawa, and K. Kubo Early thrombolysis by recombinant tissue-plasminogen activator is beneficial to the ischemic myocardium J Pharmacobiodyn 15 1992 33
J.T. Lie, P.C. Pairolero, K.E. Holley, and J.L. Titus Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs J Thorac Cardiovasc Surg 69 1975 599
M.C. Fishbein, S. Meerbaum, and J. Rit Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique Am Heart J 101 1981 593
K. Sunagawa, W.L. Maughan, and K. Sagawa Effect of regional ischemia on the left ventricular end-systolic pressure-volume relationship of isolated canine hearts Circ Res 52 1983 170
D.A. Kass, P. Marino, W. Maughan, and K. Sagawa Determinants of end-systolic pressure-volume relations during acute regional ischemia in situ Circulation 80 1989 1783
R. Coleman, I. Kennedy, and P. Humphrey Comprehensive medicinal chemistry vol. 3: membranes and receptors J. Emmett Prostanoids and their receptors 1990 Pergamon Press Oxford, UK 643
S.J. Coker, J.R. Parratt, I.M. Ledingham, and I.J. Zeitlin Thromboxane and prostacyclin release from ischaemic myocardium in relation to arrhythmias Nature 291 1981 323
N. Bowling, G.P. Dube, and W.L. Kurtz Characterization of thromboxane A2/prostaglandin H2 binding sites in guinea pig cardiac membrane preparations J Mol Cell Cardiol 26 1994 915
T. Imamoto, Z. Terashita, M. Tanabe, K. Nishikawa, and M. Hirata Protective effect of a novel thromboxane synthetase inhibitor, CV-4151, on myocardial damage due to coronary occlusion and reperfusion in the hearts of anesthetized dogs J Cardiovasc Pharmacol 8 1986 832
K.M. Mullane, and D. Fornabaio Thromboxane synthetase inhibitors reduce infarct size by a platelet-dependent, aspirin-sensitive mechanism Circ Res 62 1988 668
W.W. Nichols, J. Mehta, T.J. Wargovich, D. Franzini, and D. Lawson Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonist Angiology 40 1989 209
K. Schror, and C. Thiemermann Treatment of acute myocardial ischaemia with a selective antagonist of thromboxane receptors (BM 13.177) Br J Pharmacol 87 1986 631
M.E. Brezinski, A. Yanagisawa, and A.M. Lefer Cardioprotective actions of specific thromboxane receptor antagonist in acute myocardial ischemia J Cardiovasc Pharmacol 9 1987 65
C.E. Hock, M.E. Brezinski, and A.M. Lefer Anti-ischemic actions of a new thromboxane receptor antagonist, SQ-29,548, in acute myocardial ischemia Eur J Pharmacol 122 1986 213
T. Hohlfeld, J. Meyer-Kirchrath, Y.C. Vogel, and K. Schror Reduction of infarct size by selective stimulation of prostaglandin EP(3) receptors in the reperfused ischemic pig heart J Mol Cell Cardiol 132 2000 285
F. White, and C. Bloor Coronary collateral circulation in the pig: correlation of collateral flow with coronary bed size Basic Res Cardiol 76 1981 189
W. Schaper, G. Görge, B. Winkler, and J. Schaper The collateral circulation of the heart Prog Cardiovasc Dis 31 1988 57
S. Miyazaki, H. Fujiwara, and T. Onodera Quantitative analysis of contraction band and coagulation necrosis after ischemia and reperfusion in the porcine heart Circulation 75 1987 1074
I.M. Taylor, N.A. Shaikh, and E. Downar Ultrastructural changes of ischemic injury due to coronary artery occlusion in the porcine heart J Mol Cell Cardiol 16 1984 79
R.B. Jennings, and C.E. Ganote Mitochondrial structure and function in acute myocardial ischemic injury Circ Res 38 Suppl. 1 1976 I80
L.C. Becker, R.W. Jeremy, J. Schaper, and W. Schaper Ultrastructural assessment of myocardial necrosis occurring during ischemia and 3-h reperfusion in the dog Am J Physiol 277 1999 H243
L. Ryden, H. Tadokoro, and P.O. Sjoquist Pharmacokinetic analysis of coronary venous retro infusion: a comparison with anterograde coronary artery drug administration using metoprolol as a tracer J Am Coll Cardiol 18 1991 603
C.Y. Xiao, A. Hara, and K. Yuhki Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia-reperfusion injury: a study using mice lacking their respective receptors Circulation 104 2001 2210
